Comparative Study Assessing Multiple Switches Between Biosimilar ABP 501 (adalimumab-atto) and Adalimumab Reference Product in Patients with Plaque Psoriasis. - Yamauchi PS; Chow V; Mytych DT; Zhou M; Radziszewski W (Advances in therapy, 2026)